+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
From
From
From
From
Type 2 Diabetes Treatment: Global Market Outlook - Product Thumbnail Image

Type 2 Diabetes Treatment: Global Market Outlook

  • Report
  • December 2022
  • 66 Pages
  • Global
From
Anti-Obesity Drugs Market 2024-2028 - Product Thumbnail Image

Anti-Obesity Drugs Market 2024-2028

  • Report
  • May 2024
  • 166 Pages
  • Global
From
From
From
Type 1 Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Type 1 Diabetes - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 220 Pages
  • Global
From
From
LEVEMIR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LEVEMIR Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Type 1 Diabetes Market Report and Forecast 2024-2032 - Product Thumbnail Image

Type 1 Diabetes Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Loading Indicator